July 23, 2016 8:43 PM ET

Healthcare Equipment and Supplies

Company Overview of Entellus Medical, Inc.

Company Overview

Entellus Medical, Inc., a medical technology company, focuses on the design, development, and commercialization of products for the minimally invasive treatment of patients suffering from chronic and recurrent sinusitis. The company offers XprESS Multi-Sinus Dilation family of products consisting of XprESS Pro device, XprESS LoProfile device, and XprESS Ultra device, which open an obstructed or narrowed drainage pathway of a sinus cavity by means of trans-nasal balloon sinus dilation. It also provides PathAssist tools, such as LED Light Fiber, a single-use tool that provides real-time high intensity red trans-illumination of the sinus cavity with its battery power; Light Fiber, a single-use ...

3600 Holly Lane North

Suite 40

Plymouth, MN 55447

United States

Founded in 2006

243 Employees

Phone:

763-463-1595

Key Executives for Entellus Medical, Inc.

Chief Executive Officer, President and Director
Age: 54
Total Annual Compensation: $442.5K
Vice President of Business Development & Strategy
Age: 43
Total Annual Compensation: $90.1K
Vice President of Sales
Age: 49
Total Annual Compensation: $290.0K
Compensation as of Fiscal Year 2015.

Entellus Medical, Inc. Key Developments

Entellus Medical, Inc. Reaffirms Earnings Guidance for the Second Quarter and Full Year of 2016

Entellus Medical, Inc. reaffirmed earnings guidance for the second quarter and full year of 2016. The company continues to expect full year 2016 revenue will be in a range of $73.0 million to $77.0 million, representing annual growth of 19% to 25% and that gross margin will be in a range of 75.0% to 77.0% for 2016. Full year 2016 net loss is expected to be in a range of $21.0 million to $29.0 million. The company continues to expect second quarter 2016 revenue will range from approximately $17.8 million to $18.8 million, representing same quarter growth of 17% to 24% and that gross margin will be in a range of 75.0% to 77.0% for the second quarter of 2016. Second quarter net loss is expected to be in the range of $5.6 million to $7.6 million.

Entellus Medical, Inc. and Fiagon NA Corporation Enter into an Amended and Restated Distributor Agreement

Entellus Medical, Inc. and Fiagon NA Corporation entered into an amended and restated distributor agreement, which expands the scope of the parties' prior arrangement in their prior distributor agreement effective August 10, 2015. Pursuant to the Amended and Restated Agreement, the Company will purchase and resell certain Fiagon surgical navigation systems, components and parts in the United States certain other U.S. territories and Canada. Subject to certain exceptions for third parties that currently distribute the Fiagon products, during the term of the Amended and Restated Agreement, the Company will be the exclusive distributor of Fiagon surgical navigation systems, components, parts and related ancillary products to ear, nose and throat physicians in hospitals, physician offices, clinics and surgery centers located in the Territory and the exclusive distributor to hospitals in the Territory of Fiagon, GuideWires that are attached to or sold with the Company's balloon products. Fiagon has agreed not to collaborate with or support the competitors of the Company or any company intending to develop or commercialize products that are competitive with the Fiagon products or the Company's balloon products in the Territory during the term of the Agreement. The initial term of the Amended and Restated Agreement will expire on August 9, 2020. The Amended and Restated Agreement will automatically renew in successive 24-month periods unless either the Company or Fiagon provides to the other party written notice of non-renewal at least 365 days prior to the end of the then-current term.

Entellus Medical, Inc. Presents at The William Blair & Company 36th Annual Growth Stock Conference, Jun-15-2016 10:00 AM

Entellus Medical, Inc. Presents at The William Blair & Company 36th Annual Growth Stock Conference, Jun-15-2016 10:00 AM. Venue: The Four Seasons Hotel, 120 East Delaware Place, Chicago, IL 60611, United States.

Similar Private Companies By Industry

Company Name Region
.decimal, Inc. United States
20/20 GeneSystems, Inc. United States
20/20 Imaging LLC United States
21st Century Scientific, Inc. United States
21X Corporation United States

Recent Private Companies Transactions

Type
Date
Target
Merger/Acquisition
June 29, 2016
CogENT Therapeutics, LLC
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Entellus Medical, Inc., please visit www.entellusmedical.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.